Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cells
9d ago· 1 min readNews
Source
Deep phenotyping reveals that CD19-CAR T cell therapy in SSc patients shows potential in reversing skin fibrosis. Explore how molecular insights from this study may drive innovation. PMID:42177178, Nat Commun 2026, @NatureComms #Medsky #Pharmsky #RNA 🧪
You might also wanna read

AI-guided discovery identifies GPNMB as promising CAR T cell target for multiple cancers
Researchers developed an AI-driven framework for discovering CAR T cell therapy targets by integrating single-cell RNA sequencing data from
cell.com·9d ago

Antibody-ligand motif optimization enables multitarget switchable CAR-T therapy against solid tumors
This article presents a research study on optimizing a multitarget switchable CAR-T (sCAR-T) strategy to overcome antigenic heterogeneity an
cell.com·8d ago

OHSU logra un gran avance en la ciencia médica con las terapias celulares
Oregon Health & Sciences University·8d ago
Dual tumour–myeloid targeting of glioblastoma with GPNMB CAR-T cells
Nature Communications

OHSU advances massive leap in medical science with cellular therapies
Oregon Health & Sciences University·8d ago
Efficient mRNA delivery to resting T cells to reverse HIV latency
nature.com·1y ago

Comments
Sign in to join the conversation.
No comments yet. Be the first.